The prolyl oligopeptidase inhibitor KYP-2047 is not readily bioavailable to bloodstream form trypanosomes and human myelocytic leukemia cells
-
Published:2015
Issue:1
Volume:6
Page:7
-
ISSN:0976-9234
-
Container-title:Journal of Pharmaceutical Negative Results
-
language:en
-
Short-container-title:J Pharm Negative Results
Author:
Steverding Dietmar,Ajoko Chinenye
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology